Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study

BACKGROUND: Few data exist regarding the long‐term effectiveness of golimumab in ulcerative colitis. No data have been reported on real‐world continuous clinical response. OBJECTIVE: This study aimed to describe the long‐term outcomes in a large cohort of patients on golimumab who had ulcerative col...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Pugliese, Daniela, Privitera, Giuseppe, Rogai, Francesca, Variola, Angela, Viola, Anna, Laterza, Lucrezia, Privitera, Antonino C., Allocca, Mariangela, Bossa, Fabrizio, Cappello, Maria, Daperno, Marco, Lorenzon, Greta, Mazzuoli, Silvia, Principi, Mariabeatrice, Sablich, Renato, Moser, Luisa, Ferronato, Antonio, Traini, Sara, Tapete, Gherardo, Bodini, Giorgia, Di Girolamo, Maria, Grossi, Laurino, Mocci, Giammarco, Ricci, Chiara, Saibeni, Simone, Festa, Stefano, Spagnuolo, Rocco, Cortelezzi, Claudio C., Mocciaro, Filippo, Rizzello, Fernando, Armuzzi, Alessandro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Inflammatory Bowel Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259241/
https://ncbi.nlm.nih.gov/pubmed/33203342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620974308
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados